×
About 71,638 results

ALLMedicine™ Colitis Center

Research & Reviews  33,467 results

Loss of IL-10 signaling promotes IL-22 dependent host defenses against acute Clostridio...
https://doi.org/10.1128/IAI.00730-20
Infection and Immunity; Cribas ES, Denny JE et. al.

Mar 2nd, 2021 - Infection with the bacterial pathogen Clostridioides difficile causes severe damage to the intestinal epithelium that elicits a robust inflammatory response. Markers of intestinal inflammation accurately predict clinical disease severity. However,...

The impact of clinical symptoms and endoscopic and histologic disease activity on healt...
https://doi.org/10.1007/s11136-021-02787-4 10.1093/ecco-jcc/jjv002 10.1097/MEG.0b013e3282f16a62 10.1097/00042737-200309000-00012 10.1080/003655202317316097 10.1093/ecco-jcc/jjy024 10.1111/j.1572-0241.2001.03801.x 10.1111/j.1572-0241.2007.01094.x 10.1002/ibd.23022 10.1053/j.gastro.2013.05.048 10.1053/j.gastro.2011.10.032 10.1111/j.1365-2036.2012.05107.x 10.1111/j.1365-2036.2011.04701.x 10.1053/gast.2001.20912 10.1053/j.gastro.2011.06.054 10.1136/gut.2007.138248 10.1016/j.cgh.2016.01.015 10.1053/j.gastro.2007.08.001 10.1136/gut.2003.038505 10.1053/j.gastro.2003.11.010 10.1007/DCR.0b013e31819ad456 10.1002/ibd.20997 10.1016/j.crohns.2011.11.001 10.1016/j.crohns.2014.08.011 10.1038/ajg.2015.233 10.1016/j.bpg.2018.05.001 10.1016/j.cgh.2013.07.022 10.1111/j.1572-0241.2004.04071.x 10.1016/j.crohns.2013.11.017 10.1007/s11136-014-0797-2 10.1097/MEG.0b013e32835414b2 10.1111/apt.13387 10.1186/s12876-015-0239-9 10.1093/ecco-jcc/jjv081 10.1007/s10620-016-4180-8 10.1002/ibd.22879 10.1111/j.1572-0241.2005.40641.x 10.1002/ibd.20520 10.1002/ibd.21925 10.1002/ibd.21445 10.1016/j.cgh.2013.02.030 10.1093/ecco-jcc/jjw049 10.1016/0016-5085(87)90621-4 10.1136/gut.47.3.404 10.1038/ajg.2016.50 10.1016/S0016-5085(89)80080-0 10.1093/biomet/75.4.800 10.1053/j.gastro.2006.12.038 10.1038/nrgastro.2009.203 10.1016/j.crohns.2011.06.009 10.1016/j.crohns.2007.11.001 10.1093/ibd/izx041 10.1136/bmj.d556 10.1186/s41687-018-0046-5 10.1056/NEJM198712243172603 10.1111/j.1572-0241.2000.01676.x 10.1111/j.1572-0241.2001.04682.x 10.1016/0016-5085(94)90585-1
Quality of Life Research : an International Journal of Qu... Yarlas A, Willian MK et. al.

Mar 2nd, 2021 - Studies of patients with ulcerative colitis (UC) report that reduced clinical symptoms and endoscopic activity predict better health-related quality of life (HRQoL). However, no study has examined the joint and unique associations of clinical and ...

Polyphenols from food by-products: An alternative or complementary therapy to IBD conve...
https://doi.org/10.1016/j.foodres.2020.110018
Food Research International (Ottawa, Ont.); Machado APDF, Geraldi MV et. al.

Mar 2nd, 2021 - Inflammatory bowel diseases (IBD) are illnesses characterized by chronic intestinal inflammation and microbial dysbiosis that have emerged as a public health challenge worldwide. It comprises two main conditions: Crohn's disease and ulcerative col...

Gut microbiota shape the inflammatory response in mice with an epithelial defect.
https://doi.org/10.1080/19490976.2021.1887720
Gut Microbes; Wang R, Moniruzzaman M et. al.

Mar 1st, 2021 - Intestinal epithelial cell endoplasmic reticulum (ER) stress has been implicated in intestinal inflammation. It remains unclear whether ER stress is an initiator of or a response to inflammation. Winnie mice, carrying a Muc2 gene mutation resultin...

Systematic Scoring Analysis for Intestinal Inflammation in a Murine Dextran Sodium Sulf...
https://doi.org/10.3791/62135
Journal of Visualized Experiments : JoVE; Garcia-Hernandez V, Neumann PA et. al.

Mar 1st, 2021 - Murine colitis models are tools that are extensively employed in studies focused on understanding the pathobiology of inflammatory intestinal disorders. However, robust standards for objective and reproducible quantification of disease severity re...

see more →

Guidelines  119 results

AGA Clinical Practice Update on Diagnosis and Management of Immune Checkpoint Inhibitor...
https://doi.org/10.1053/j.gastro.2020.08.063
Gastroenterology Dougan M, Wang Y et. al.

Oct 20th, 2020 - Immune checkpoint inhibitors (ICIs) have transformed the treatment landscape for oncology, leading to durable remissions in a subset of patients, but also a broad range of potentially life-threatening inflammatory toxicities, many of which involve...

Spatialization in working memory: can individuals reverse the cultural direction of the...
https://doi.org/10.1016/j.gastrohep.2020.05.009
Annals of the New York Academy of Sciences References; Muñoz F, Ripollés T et. al.

Sep 26th, 2020 - Ultrasound has an excellent diagnostic performance when Crohn's disease is suspected, when performing an activity assessment, or determining the extension and location of Crohn's disease, very similar to other examinations such as MRI or CT. It ha...

Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice r...
https://doi.org/10.1007/s00520-020-05707-3
Supportive Care in Cancer : Official Journal of the Multi... Dougan M, Blidner AG et. al.

Aug 28th, 2020 - Immune-related adverse events (IrAEs) affecting the gastrointestinal (GI) tract and liver are among the most frequent and most severe inflammatory toxicities from contemporary immunotherapy. Inflammation of the colon and or small intestines (enter...

Pharmacological Management of Adult Outpatients With Moderate to Severely Active Ulcera...
https://doi.org/10.1053/j.gastro.2020.03.011
Gastroenterology

Mar 28th, 2020 - Pharmacological Management of Adult Outpatients With Moderate to Severely Active Ulcerative Colitis: Clinical Decision Support Tool.|2020| ,|

Spotlight: Management of Moderate-to-Severe Ulcerative Colitis.
https://doi.org/10.1053/j.gastro.2020.03.012
Gastroenterology Feuerstein JD, Isaacs KL et. al.

Mar 14th, 2020 - Spotlight: Management of Moderate-to-Severe Ulcerative Colitis.|2020|Feuerstein JD,Isaacs KL,Schneider Y,Siddique SM,Falck-Ytter Y,|

see more →

Drugs  857 results see all →

Clinicaltrials.gov  35,445 results

Loss of IL-10 signaling promotes IL-22 dependent host defenses against acute Clostridio...
https://doi.org/10.1128/IAI.00730-20
Infection and Immunity; Cribas ES, Denny JE et. al.

Mar 2nd, 2021 - Infection with the bacterial pathogen Clostridioides difficile causes severe damage to the intestinal epithelium that elicits a robust inflammatory response. Markers of intestinal inflammation accurately predict clinical disease severity. However,...

The impact of clinical symptoms and endoscopic and histologic disease activity on healt...
https://doi.org/10.1007/s11136-021-02787-4 10.1093/ecco-jcc/jjv002 10.1097/MEG.0b013e3282f16a62 10.1097/00042737-200309000-00012 10.1080/003655202317316097 10.1093/ecco-jcc/jjy024 10.1111/j.1572-0241.2001.03801.x 10.1111/j.1572-0241.2007.01094.x 10.1002/ibd.23022 10.1053/j.gastro.2013.05.048 10.1053/j.gastro.2011.10.032 10.1111/j.1365-2036.2012.05107.x 10.1111/j.1365-2036.2011.04701.x 10.1053/gast.2001.20912 10.1053/j.gastro.2011.06.054 10.1136/gut.2007.138248 10.1016/j.cgh.2016.01.015 10.1053/j.gastro.2007.08.001 10.1136/gut.2003.038505 10.1053/j.gastro.2003.11.010 10.1007/DCR.0b013e31819ad456 10.1002/ibd.20997 10.1016/j.crohns.2011.11.001 10.1016/j.crohns.2014.08.011 10.1038/ajg.2015.233 10.1016/j.bpg.2018.05.001 10.1016/j.cgh.2013.07.022 10.1111/j.1572-0241.2004.04071.x 10.1016/j.crohns.2013.11.017 10.1007/s11136-014-0797-2 10.1097/MEG.0b013e32835414b2 10.1111/apt.13387 10.1186/s12876-015-0239-9 10.1093/ecco-jcc/jjv081 10.1007/s10620-016-4180-8 10.1002/ibd.22879 10.1111/j.1572-0241.2005.40641.x 10.1002/ibd.20520 10.1002/ibd.21925 10.1002/ibd.21445 10.1016/j.cgh.2013.02.030 10.1093/ecco-jcc/jjw049 10.1016/0016-5085(87)90621-4 10.1136/gut.47.3.404 10.1038/ajg.2016.50 10.1016/S0016-5085(89)80080-0 10.1093/biomet/75.4.800 10.1053/j.gastro.2006.12.038 10.1038/nrgastro.2009.203 10.1016/j.crohns.2011.06.009 10.1016/j.crohns.2007.11.001 10.1093/ibd/izx041 10.1136/bmj.d556 10.1186/s41687-018-0046-5 10.1056/NEJM198712243172603 10.1111/j.1572-0241.2000.01676.x 10.1111/j.1572-0241.2001.04682.x 10.1016/0016-5085(94)90585-1
Quality of Life Research : an International Journal of Qu... Yarlas A, Willian MK et. al.

Mar 2nd, 2021 - Studies of patients with ulcerative colitis (UC) report that reduced clinical symptoms and endoscopic activity predict better health-related quality of life (HRQoL). However, no study has examined the joint and unique associations of clinical and ...

Polyphenols from food by-products: An alternative or complementary therapy to IBD conve...
https://doi.org/10.1016/j.foodres.2020.110018
Food Research International (Ottawa, Ont.); Machado APDF, Geraldi MV et. al.

Mar 2nd, 2021 - Inflammatory bowel diseases (IBD) are illnesses characterized by chronic intestinal inflammation and microbial dysbiosis that have emerged as a public health challenge worldwide. It comprises two main conditions: Crohn's disease and ulcerative col...

Gut microbiota shape the inflammatory response in mice with an epithelial defect.
https://doi.org/10.1080/19490976.2021.1887720
Gut Microbes; Wang R, Moniruzzaman M et. al.

Mar 1st, 2021 - Intestinal epithelial cell endoplasmic reticulum (ER) stress has been implicated in intestinal inflammation. It remains unclear whether ER stress is an initiator of or a response to inflammation. Winnie mice, carrying a Muc2 gene mutation resultin...

Systematic Scoring Analysis for Intestinal Inflammation in a Murine Dextran Sodium Sulf...
https://doi.org/10.3791/62135
Journal of Visualized Experiments : JoVE; Garcia-Hernandez V, Neumann PA et. al.

Mar 1st, 2021 - Murine colitis models are tools that are extensively employed in studies focused on understanding the pathobiology of inflammatory intestinal disorders. However, robust standards for objective and reproducible quantification of disease severity re...

see more →

News  1,645 results

PICaSSO Tool Promising for Predicting Histologic Remission in Ulcerative Colitis
https://www.medscape.com/viewarticle/946588

Feb 28th, 2021 - NEW YORK (Reuters Health) - The recently developed Paddington International Virtual ChromoendoScopy ScOre (PICaSSO) accurately identified both endoscopic and histologic remission in ulcerative colitis (UC) and predicted specified clinical outcomes...

Ustekinumab Works Well in Ulcerative Colitis in the General Population
https://www.medscape.com/viewarticle/946043

Feb 18th, 2021 - NEW YORK (Reuters Health) - The monoclonal antibody ustekinumab (Stelara, Janssen) appears to be at least as effective against ulcerative colitis (UC) in real-world practice as it was in the clinical trials that led to its approval, according to n...

Xeljanz, Xeljanz XR (tofacitinib): Drug Safety Communication - Initial Safety Trial Results Find Increased Risk of Serious Heart-related Problems and Cancer with Arthritis and Ulcerative Colitis Me...
https://www.fda.gov/safety/medical-product-safety-information/xeljanz-xeljanz-xr-tofacitinib-drug-safety-communication-initial-safety-trial-results-find-increased

[Posted 02/04/2021] AUDIENCE: Patient, Health Professional, Pharmacy, Rheumatology, Gastroenterology, Cardiology, Oncology  ISSUE: The FDA is alerting the public that preliminary results from a safety clinical trial show an increased risk of serio...

Defining Wellness in IBD
https://www.medscape.com/viewarticle/945208

Feb 2nd, 2021 - Physicians treating patients with IBD typically focus on disease and symptom management along with quality of life measures, but the latter are not the final word on patient well-being. Social well-being is another outcome that can more accurately...

IV Ferric Carboxymaltose Tops IV Iron Sucrose for Iron-deficiency Anemia in IBD
https://www.medscape.com/viewarticle/945009

Feb 1st, 2021 - NEW YORK (Reuters Health) - For iron-deficiency anemia (IDA) in patients with inflammatory bowel disease (IBD), intravenous ferric carboxymaltose is probably a better bet than IV iron sucrose, according to a Cochrane review of therapies to treat I...

see more →

Patient Education  105 results see all →